Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Past Research Scholars
| Name | Project Title | Year |
| Betsy Salazar, PhD | Spinal and Supraspinal Regions Involved in Control of Bladder Function After a Spinal Cord Injury | 2023-2025 |
| Christi Butler, MD | The Utility of Conjoint Analysis with patient-decision making for GAS |
2023-2025 |
| Iman Al-Naggar, PhD | Targeting Aging Pathways in Lower Urinary Tract Dysfunction | 2023-2025 |
| Maya Chandru (Overland), MD, PhD | In vivo testing of bacterial microtraps as a novel mechanical antibiotic alternative for the urinary tract | 2023-2025 |
| Richa Singh, PhD | Characterizing the mechanistic co-operation of DNMT and EZH2 in mediating lineage plasticity in advanced prostate cancer | 2023-2025 |
| Bashir Al Hussein Al Awamlh, MD | Assessment of resource utilization following treatment of localized prostate cancer using a novel data source | 2023–2024 |
| Christopher Gaffney, MD | Inducing anti-tumor immunity in localized and metastatic prostate cancer using a novel intratumoral agonist anti-CD40 antibody as a cancer "vaccine" | 2023–2024 |
| Heiko Yang, MD, PhD | The role of macrophages in Randall's plaque formation | 2023–2024 |
| Joshua Linscott, MD, PhD | Utilizing Cell Free DNA to Detect Minimal Residual Disease and Monitor Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer | 2023–2024 |
| Meera Chappidi, MD | Development and validation of a novel prognostic biomarker model to improve risk stratification of prostate cancer patients on active surveillance | 2023–2024 |
| Unwanaobong Nseyo, MD | Characterizing provider-driven disparities in advanced therapies for overactive bladder among racial/ethnic minority women | 2023–2024 |
| Wilson Sui, MD | A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Ureteroscopy in Moderate to High Infectious Risk Population | 2023–2024 |
| Yufen Zhang, MD, PhD | The spinal mechanism of pelvic pain sensitization and voiding dysfunction |
2023–2024 |
| Asmaa El-Kenawi, PhD | Identifying Immune Tumor Cell Metabolic Dependencies in Prostate Cancer | 2022-2024 |
| Firoj Alom, PhD | Development of an Optogenetic-Based Strategy for Controlling the External Urethral Sphincter | 2022-2024 |
| Joshua Halpern, MD | The Role of Low Testosterone in Perioperative Surgical Outcomes | 2022-2024 |
| Juan Javier-DesLoges, MD | A Pilot Study to Improve Germline Testing in At-Risk Patients with Prostate Cancer | 2022-2024 |
| Kait Al, PhD | The Role of Toxic Xenobiotics and the Gut Microbiota in Kindey Stone Formation |
2022-2024 |
| Nathalia Amado, PhD | Mechanism of Interaction of FLNA and MYOCD on Smooth Muscle Development and Association with Prune Belly Syndrome | 2022-2024 |
| Nirmish Singla, MD | Tumor Evolution of Brain-Specific Tropism in Metastatic Renal Cell Carcinoma | 2022-2024 |
| Nnenaya Mmonu, MD | Development of Patient Reported Outcome Measures for Genital Gender-Affirming Surgery | 2022-2024 |
| Robert Potter, PhD | Genomic Diversity Driving the Commensal-Pathogen Axis in the Urogenital Tract |
2022-2024 |
| Weiping Li, PhD | Harnessing Ferroptosis in Treating Advanced Prostate Cancer | 2022-2024 |